ArticleDrug design, development and therapy2023

Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis.

Huan Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.